Short-term Efficacy of Botulinum Toxin A for Refractory Overactive Bladder in Female Patients
In Vivo · 2025
DOI: 10.21873/invivo.13899 ↗Kurz gefasst
Klinische Studie in der Zeitschrift In Vivo, 2025. Verfasst von Hirotaka Sato und 3 weiteren Autor:innen. Beteiligte Einrichtung: Urological Chief Surgeon, Department of Urology, Hokusuikai Kinen Hospital, Ibaraki, Japan; hirotakasato911@yahoo.co.jp. Hauptthemen laut MEDLINE: Botulinum Toxins, Type A, Urinary Bladder, Overactive. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Urological Chief Surgeon, Department of Urology, Hokusuikai Kinen Hospital, Ibaraki, Japan; hirotakasato911@yahoo.co.jp.
- Urological Chief Laboratory Technician, Department of Clinical Laboratory, Hokusuikai Kinen Hospital, Ibaraki, Japan.
- Urological Chief Surgeon, Department of Urology, Hokusuikai Kinen Hospital, Ibaraki, Japan.
- Orthopedics Chief Surgeon, Department of Orthopaedic Surgery, Hokusuikai Kinen Hospital, Ibaraki, Japan.
Zitieren
APA
Sato, H., Watanabe, T., Otsuka, S., & Tsukada, S. (2025). Short-term Efficacy of Botulinum Toxin A for Refractory Overactive Bladder in Female Patients. In Vivo. https://doi.org/10.21873/invivo.13899
Vancouver
Sato H, Watanabe T, Otsuka S, Tsukada S. Short-term Efficacy of Botulinum Toxin A for Refractory Overactive Bladder in Female Patients. In Vivo. 2025. doi:10.21873/invivo.13899
BibTeX
@article{Sato2025,
author = {Sato, Hirotaka and Watanabe, Takahiro and Otsuka, Shota and Tsukada, Sachiyuki},
title = {Short-term Efficacy of Botulinum Toxin A for Refractory Overactive Bladder in Female Patients},
journal = {In Vivo},
year = {2025},
doi = {10.21873/invivo.13899}
}
EUVIMED